Since taking office in May 2017, Food and Drug Administration head Scott Gottlieb has set about working to make drug approval a less “slow and burdensome” process. In one case, though, the drug approval process might have moved a little too quickly, according to the independent watchdog group the Project on Government…
Source: Gizmodo – After a Biotech Exec Got Chummy With Trump and the FDA, His Drug Was Fast-Tracked